SCHEMBL23739980

SCHEMBL23739980

CC(=O)Nc1cc(C)cc2cc[nH]c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 1/20 0.47
▸ MAOA P21397 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ GRM5 P41594 5/20 0.40
▸ BTK Q06187 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ KMT2A Q03164 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.38
▸ MAPT P10636 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ PIK3C3 Q8NEB9 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ PTPRC P08575 1/20 0.37
▸ PTPN2 P17706 1/20 0.37
▸ PTPN1 P18031 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25351455 0.84 ROCK2 (0.47) ROCK2MAOAMAOBGRM5BTK
SCHEMBL31607389 0.83 ROCK2 (0.46) ROCK2MAOAMAOBGRM5BTK
SCHEMBL18661406 0.83 ROCK2 (0.46) ROCK2MAOAMAOBGRM5BTK
SCHEMBL30088006 0.79 XDH (0.46) ROCK2MAOAMAOBGRM5BTK
SCHEMBL28601707 0.79 XDH (0.46) ROCK2MAOAMAOBGRM5BTK
SCHEMBL27565169 0.78 NR3C1 (0.38) GRM5NR3C1PGRNR3C2AR
SCHEMBL6091339 0.77 NR3C1 (0.57) ROCK2GRM5BTKALDH1A1HPGD
SCHEMBL31456523 0.77 NR3C1 (0.57) ROCK2GRM5BTKALDH1A1HPGD
SCHEMBL21805739 0.76 ROCK2 (0.40) ROCK2MAOAMAOBGRM5BTK
SCHEMBL987784 0.71 KEAP1 (0.56) MAOBALDH1A1HPGDKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3492474-B1 INTERMEDIATES USED IN THE PRODUCTION OF DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS GLAXOSMITHKLINE LLC (US) 2021-08-11 — — EP disclosed
Send feedback